Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1991 1
1993 3
1994 1
1995 1
1997 3
1999 3
2000 4
2001 4
2002 4
2003 10
2004 7
2005 10
2006 7
2007 4
2008 3
2009 1
2010 2
2011 1
2013 7
2014 1
2015 2
2016 1
2017 2
2018 2
2019 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 16334170

84 results
Results by year
Filters applied: . Clear all
Page 1
Serum levels of soluble syndecan-1 in Hodgkin's lymphoma.
Vassilakopoulos TP, Kyrtsonis MC, Papadogiannis A, Nadali G, Angelopoulou MK, Tzenou T, Dimopoulou MN, Siakantaris MP, Kontopidou FN, Kalpadakis C, Kokoris SI, Dimitriadou EM, Tsaftaridis P, Pizzolo G, Pangalis GA. Vassilakopoulos TP, et al. Anticancer Res. 2005 Nov-Dec;25(6C):4743-6. Anticancer Res. 2005. PMID: 16334170 Free article.
Soluble syndecan-1 level at diagnosis is an independent prognostic factor in multiple myeloma and the extent of fall from diagnosis to plateau predicts for overall survival.
Lovell R, Dunn JA, Begum G, Barth NJ, Plant T, Moss PA, Drayson MT, Pratt G; Working Party on Leukaemia in Adults of the National Cancer Research Institute Haematological Oncology Clinical Studies Group. Lovell R, et al. Br J Haematol. 2005 Aug;130(4):542-8. doi: 10.1111/j.1365-2141.2005.05647.x. Br J Haematol. 2005. PMID: 16098068
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Herling M, Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S, Bonfante V, Giardini R, Chilosi M, Kittas C, Gianni AM, Bonadonna G, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH. Herling M, et al. Clin Cancer Res. 2003 Jun;9(6):2114-20. Clin Cancer Res. 2003. PMID: 12796376
84 results